Navigation Links
Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder

and at least twice the incidence of sugar pill) were: nausea; fatigue; dry mouth; somnolence; constipation; insomnia; appetite decreased; hyperhidrosis; libido decreased; vomiting; ejaculation delayed; and erectile dysfunction. Approximately 16 percent of patients taking Cymbalta discontinued treatment due to an adverse event compared to 4 percent of patients receiving sugar pill. The most common adverse events reported as reasons for discontinuation (occurring at a rate of less than or equal to 1.2 percent and at a significantly higher rate compared to sugar pill) were nausea, vomiting and dizziness.(3)

Methods

Data from two double-blind, placebo-controlled trials in adults with generalized anxiety disorder were pooled. In the first trial, patients received 60 mg of Cymbalta once daily, 120 mg once daily or sugar pill for nine weeks. In the second trial, patients were started at a dose of 60 mg of Cymbalta but dose could be increased to 120 mg once daily, or they were given sugar pill for 10 weeks.

In both trials, the Hamilton Anxiety Scale (HAMA) was used to measure anxious symptoms, the SDS was used to assess global functional impairment and the Visual Analog Scale for Overall Pain (VAS) was used to measure severity of painful physical symptoms. Pearson partial correlations were used to assess the magnitude and significance of the associations between global functional impairment and psychic anxiety or painful physical symptoms. Path analysis was used to assess the relative contributions of changes in psychic and somatic anxiety and painful physical symptoms on improved functional outcomes.

The large unexplained effect of Cymbalta implies that Cymbalta improves global functioning through the treatment of additional symptoms that the scales in our clinical trials do not measure. These symptoms could be related to other anxious symptoms, painful physical sym
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
2. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
5. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
9. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
10. Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
11. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
Post Your Comments:
(Date:4/21/2015)... --  iRhythm Technologies, Inc. , a leading digital healthcare solutions ... today that Banner Health, one of the largest nonprofit ... offering iRhythm,s ZIO ® Service to patients in ... Banner Health, we are dedicated to strengthening our patient ... John Hensing , MD, Banner Health,s executive vice president ...
(Date:4/21/2015)... 21, 2015  Decision Diagnostics Corp. (OTC PINK: ... exclusive worldwide sales, service and regulatory processes agent ... Alternative Strip, specifically designed to work with the ... family of glucose testing meters, the most popular ... Johnson & Johnson/Lifescan has requested an unscheduled Case ...
(Date:4/21/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that 2015 first quarter financial results ... that day, the Company will hold a teleconference call ... discuss the results, followed by a question and answer ... and Chief Executive Officer of CryoLife, Inc. ...
Breaking Medicine Technology:Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 2Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 3Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 2Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 3CryoLife Announces Release Date and Teleconference Call Details for 2015 First Quarter Financial Results 2
... , , , , , ... PARIS and LAUSANNE, Switzerland ... innovation-driven global specialty,pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based ... of,prescription drugs that target unmet medical needs, announce the launch ...
... , THE WOODLANDS, Texas , Feb. 3 ... a biopharmaceutical company focused on discovering and developing breakthrough treatments for ... , Lexicon,s president and chief executive officer, will present at the ... on Monday, February 8, 2010 at 9:30 a.m., ...
Cached Medicine Technology:Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 2Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 3Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 4Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 5Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 6Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 2Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 3
(Date:4/21/2015)... 21, 2015 On April 2, 2015, ... to Achieve Kylie Jenner Lips With Disastrous ... injured themselves while attempting an at-home lip augmentation ... is that creating an airlock around one’s mouth for ... plump and achieve Kylie Jenner’s now famous pout. (see: ...
(Date:4/21/2015)... April 21, 2015 “ ZeroWire ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... how ZeroWire is a security system and lifestyle management ... there were over 2 million burglaries in 2010. It ...
(Date:4/21/2015)... Lewisville, TX (PRWEB) April 21, 2015 ... (NYSE:ADPT) announced today it is opening its first freestanding ... located in Chandler, Arizona and will be licensed under ... of the Dignity Health and Adeptus Health joint venture. ... Chandler Regional and Mercy Gilbert Medical Centers said the ...
(Date:4/21/2015)... Wireless Analytics, LLC , a pioneering ... the Boston Business Journal as the 25th fastest-growing private ... a recent event celebrating the 2015 Pacesetters, the ... companies in Massachusetts. , Wireless Analytics was ranked among ... the fastest revenue growth from 2011 through 2014. ...
(Date:4/21/2015)... 2015 The report “Dermatitis ... analysis on the therapeutic development for Dermatitis. ... identifying new targets and MOAs to produce ... TOC is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html ... players involved in the therapeutic development for ...
Breaking Medicine News(10 mins):Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4
... - Health Professionals Calling for Further Guidance From Department ... plastic baby bottles has,been making headlines in North America, ... that 92%(1) of mums are not aware of the ... Us are phasing out,all baby bottles containing Bisphenol-A and ...
... A new report, funded and released by,Avalere Health, showed ... its,CY 2008 Part D Formulary Reference File. In response, ... Medicare offerings in 2008,resulting in significantly smaller Part D ... driven in part to remove hundreds of prescription,drugs that ...
... A large genetic study in mice has identified hundreds of ... DNA of more than 500 lymphomas to find the cancer ... mutations in total, which together implicate almost 350 regions in ... correspond to genes known to be involved in human cancers ...
... focuses on solving real-world problems ... in radiology, ... in radiology and medical image and information management solutions,today announced that its ... at the SIIM 2008,Annual Meeting in Seattle, WA, from May 15 to ...
... Life and Casualty,Company, a national life and health insurer, ... Alzheimer,s Association Rita Hayworth Gala for,their support of the ... "Bankers Life has organized Forget Me Not Days over ... 2003 to support both national and,local efforts," said Harry ...
... the use of pacemakers,implantable cardioverter-defibrillators (ICDs) and ... May 15 The American College,of Cardiology ... Heart Rhythm,Society (HRS) have jointly released updated ... for Device-Based Therapy of,Cardiac Rhythm Abnormalities are ...
Cached Medicine News:Health News:Bounty Poll Reveals British Mums in the Dark Over Bisphenol-A in Baby Bottles 2Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 2Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 3Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 4Health News:Connecting cancer genes 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 3Health News:Bankers Life and Casualty Company Named Corporate Honoree at Alzheimer's Association Chicago Rita Hayworth Gala 2Health News:The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines 2Health News:The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines 3Health News:The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines 4
Lacrimal Cannulas, 19 g. shaft tapering to 23 g. cannula, straight. Overall length 37.5 mm. 5/box....
Anterior Chamber Needle, 27 g., 5 mm from bend to tip. Overall length 22 mm. 5/box....
Anterior Chamber Needle, 25 g. Angled. 9 mm angled tip. Overall length 19 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Straight with U-tip. U-shaped tip allows aspiration and irrigation at the 12 o'clock position. Overall length 18 mm. 5/box....
Medicine Products: